HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Screening for dementia: comparison of three commonly used instruments.

Abstract
The sensitivity and specificity of three cognitive screening measures - the Mini-Mental State Exam (MMSE), Mattis Dementia Rating Scale (MDRS), and Neurobehavioral Cognitive Status Examination (NCSE) - were compared in a cohort of subjects with dementia as well as normal elderly individuals. Twenty-two patients met criteria for probable Alzheimer' s disease (AD), 19 for vascular dementia (VaD), and 12 were normal control subjects. The use of standard cutpoints resulted in poor to good classification accuracy for the three measures, but measurable improvement in sensitivity was obtained by adjusting the cutpoints for each measure. Discriminatory power was maximized with an MMSE cutpoint of < or = 26, an MDRS cutpoint of < or = 134, and requiring one or more NCSE subtests to be in the impaired range. Use of age and education adjusted norms resulted in good to excellent classification accuracy for the MMSE and MDRS. The NCSE subtest score pattern failed to differentiate between AD and VaD.
AuthorsW G van Gorp, T D Marcotte, D Sultzer, C Hinkin, M Mahler, J L Cummings
JournalJournal of clinical and experimental neuropsychology (J Clin Exp Neuropsychol) Vol. 21 Issue 1 Pg. 29-38 (Feb 1999) ISSN: 1380-3395 [Print] England
PMID10420999 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Topics
  • Aged
  • Alzheimer Disease (diagnosis)
  • Dementia, Vascular (diagnosis)
  • Diagnosis, Differential
  • Humans
  • Neuropsychological Tests (standards)
  • Prospective Studies
  • Psychiatric Status Rating Scales (standards)
  • Reference Standards
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: